nach oben

World Journal of Urology

Erschienen in:

01.03.2007 | Topic Paper

Biopsy standards for detection of prostate cancer

verfasst von: Bob Djavan, Markus Margreiter

Erschienen in: World Journal of Urology | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

The widespread use of measurement of prostate-specific antigen for prostate cancer screening has led to a dramatic increase in the number of transrectal biopsies. Although transrectal ultrasound-guided prostate biopsy is the gold standard in the diagnosis of prostate cancer, the strategies for initial and repeat biopsies remain controversial. Over the past decade numerous biopsy protocols have been developed. Several protocols have been established that increase the number of cores by combining sextant and lateral biopsies to increase the cancer detection rate. We review the current methods of prostate biopsies, the indication to perform an initial and repeat biopsy, the impact of prostate volume on the number of cores taken, and the morbidity of the procedure.

Djavan B, Susani M, Bursa B, Basharkhah A, Simak R, Marberger M (1999) Predictability and significance of multifocal prostate cancer in the radical prostatectomy specimen. Tech Urol 5(3):139–142PubMed

Stamey TA (1995) Making the most out of six systematic sextant biopsies. Urology 45(1):2–12PubMedCrossRef

Norberg M, Egevad L, Holmberg L, Sparen P, Norlen BJ, Busch C (1997) The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 50:562–566PubMedCrossRef

Presti JC Jr, Chang JJ, Bhargava V, Shinohara K (2000) The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 163(1):163–166PubMedCrossRef

Karakiewicz PI, Aprikian AG, Meshref AW, Bazinet M (1996) Computer-assisted comparative analysis of four-sector and six section biopsies of the prostate. Urology 48:747–750PubMedCrossRef

Karakiewicz PI, Hanley JA, Bazinet M (1998) Three-dimensional computer-assisted analysis of sector biopsy of the prostate. Urology 52:208–212PubMedCrossRef

Ravery V, Billeband T, Toublanc M, Boccon-Gibod L, Hermien JF, Moulinver F, Blanc E, Delmas V (1999) Diagnostic value of the systematic TRUS-guided prostate biopsies. Eur Urol 35:298–303PubMedCrossRef

Eskew AL, Bare RL, McCullongh DL (1997) Systematic 5-region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 157:199–202PubMedCrossRef

Bauer JJ, Zeng J, Weir J, Zhang W, Sesterhern IA, Connely RR, Mun SK, Mone JW (1999) Three-dimensional computer-simulated prostate models: lateral prostate biopsies increase the detection rate of prostate cancer. Urology 53:961–967PubMedCrossRef

10.

Chang JJ, Shinohara K, Bhargava V, Presti JC Jr (1998) Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol 160:2111–2114PubMedCrossRef

11.

Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J (2006) Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 175:1605–1612PubMedCrossRef

12.

Djavan B, Zlotta AR, Ekane S, Remzi M, Kramer G, Roumeguère T, Etemad M, Ghawidel K, Schulman CC, Marberger M (2000) Is on set of sextant biopsies enough to rule out prostate cancer? Influence of transition and total prostate volumes on prostate cancer yield. Eur Urol 38(2):218–224PubMedCrossRef

13.

Uzzo RG, Wei JT, Waldbaum RS, Perlmutter AP, Byrne JC, Vaughan ED (1995) The influence of prostatic size on cancer detection. Urology 46:831–836PubMedCrossRef

14.

Chen ME, Troncoso P, Johnston DA, Tang K, Babaian RJ (1997) Optimization of prostate biopsy strategy using computer based analysis. J Urol 158:2168–2175PubMedCrossRef

15.

Djavan B, Zlotta AR, Remzi M, Bursa B, Hruby S, Wolfram R, Schulman CC, Marberger M (1999) Total and transition zone prostate volume and age: how do they affect the utility of PSA based diagnostic parameters for early prostate cancer detection? Urology 54(5):846–852PubMedCrossRef

16.

Djavan B, Zlotta AR, Byttebier G, Shariat S, Omar M, Schulman CC, Marberger M (1998) Prostate specific antigen density of the TZ for early detection of prostate cancer. J Urol 160(2):411–418PubMedCrossRef

17.

Zlotta AR, Djavan B, Marberger M, Schulmann CC (1997) Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction. J Urol 157:1315–1321PubMedCrossRef

18.

Levine MA, Ittman M, Melamed J, Lepor H (1998) Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 159:471–476PubMedCrossRef

19.

Letran JL, Meyer GE, Loberiza FR, Brawer MK (1998) The effect of prostate volume on the yield of needle biopsy. J Urol 160(5):1718–1721PubMedCrossRef

20.

Vashi AR, Wojno KJ, Gillespie B, Oesterling JE (1998) A model for the number of cores per prostate biopsy based on patient age and prostate gland volume. J Urol 159:920–924PubMedCrossRef

21.

Hodge KK, McNeal JE, Terris MK, et al (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71–74PubMed

22.

23.

Philip J, Hanchanale V, Foster CS, Javle P (2006) Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols. BJU Int 98:559–562PubMedCrossRef

24.

Bazinet M, Karakiewicz PI, Aprikian AG, et al (1996) Value of systematic TZ biopsies in the early detection of prostate cancer. J Urol 155:605–606PubMedCrossRef

25.

Terris MK, Pham TQ, Issa MM, Kabalin JN (1997) Routine TZ and seminal vesicle biopsies in all patients undergoing transrectal ultrasound giuded prostate biopsies are not indicated. J Urol 157:204–206PubMedCrossRef

26.

Epstein JI, Walsh PC, Sauvageot J, Carter HB (1997) Use of repeat sextant and transistion zone biopsies for assessing extent of prostate cancer. J Urol 158:1886–1890PubMedCrossRef

27.

Brossner C, Winterholer A, Roehlich M, Dlouhy-Schütz E, Serra V, Sonnleithner M, Grubmüller KH, Pummer K, Schuster E (2003) Distribution of prostate carcinoma foci within the peripheral zone: analysis of 8,062 prostate biopsy cores. World J Urol 21(3):163–166PubMedCrossRef

28.

Orozco R, O’Dowd GJ, Kunnel B, et al (1998) Observations on pathology trends in 62,537 protstate biopsies obtained from urology private practices in the United States. Urology 51:186–195PubMedCrossRef

29.

Bostwick DG, Qian J, Frankel K (1995) The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. J Urol 154:1791–1794PubMedCrossRef

30.

Green J, Feneley MR, Young M, Peeling B, Kirby R, Parkinson C (1996) The prevalence of prostatic intraepithelial neoplasia (PIN) in biopsies from hospital practice and pilot screening: clinical implications. J Urol 155(Suppl):A1260

31.

Raviv G, Janssen TH, Zlotta AR, Descamps F, Verhest A, Schulman CC (1996) Prostatic intraepithelial neoplasia: influence of clinical and pathological data on the detection of invasive prostate cancer, in patients initially diagnosed on previous needle biopsy. J Urol 156:1050–1055PubMedCrossRef

32.

Raviv G, Zlotta AR, Janssen TH, Descamps F, Verhest A, Schulman CC (1996) Does prostate-specific antigen and prostate-specific antigen density enhance the detection of prostate cancer in patients initially diagnosed to have prostatic intraepithelial neoplasia? Cancer 77:2103–2108PubMedCrossRef

33.

Zlotta AR, Raviv G, Schulman CC (1996) Clinical prognostic criteria for later diagnosis of prostate carcinoma in patients with initial isolated prostatic intraepithelial neoplasia. Eur Urol 30:249–255PubMed

34.

Meyer F, Tetu B, Bairati I, Lacombe L, Fradet Y (2006) Prostatic intraepithelial neoplasia in TURP specimens and subsequent prostate cancer. Can J Urol 13:3255–3260PubMed

35.

Djavan B, Zlotta AR, Remzi M, Ghawidel K, Basharkhah A, Schulman CC, Marberger M (2000) Optimal predictors of prostate cancer in repeat prostate biopsy: a prospective study in 1,051 men. J Urol 163(4):1144–1148PubMedCrossRef

36.

Irani J, Fournier F, Bon D, et al (1997) Patient tolerance of transrectal ultrasound-guided biopsy of the prostate. Br J Urol 79(4):608–610PubMed

37.

Clements R, Aideyan OU, Griffiths GJ, et al (1993) Side effects and patient acceptability of transrectal biopsy of the prostate. Clin Radiol 47:125–126PubMedCrossRef

38.

Adamakis I, Mitropoulos D, Haritopoulos K, Alamanis C, Stravodimos K, Giannopoulos A (2004) Pain during transrectal ultrasonography guided prostate biopsy: a randomized prospective trial comparing periprostatic infiltration with lidocaine with the intrarectal instillation of lidocaine-prilocain cream. World J Urol 22(4):281–284PubMedCrossRef

39.

Rodriguez LV, Terris MK (1998) Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J Urol 160:2115–2120PubMedCrossRef

40.

Cooner WH, Mosley BR, Rutherford CL, et al (1990) Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 143:1146–1152PubMed

41.

Crawford ED, Haynes AL Jr, Story MW, et al (1982) Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy. J Urol 127:449–451PubMed

42.

Davison P, Malament M (1971) Urinary contamination as a result of transrectal biopsy of the prostate. J Urol 105:545–546PubMed

43.

Fawcett DP, Eykyn S, Bultidue MI (1975) Urinary tract infection following transrectal biopsy of the prostate. Br J Urol 47:679–681PubMedCrossRef

44.

Ashby EC, Rees M, Dowding CH (1978) Prophylaxis against systemic infection after transrectal biopsy for suspected prostatic carcinoma. Br Med J 2:1263–1264PubMed

45.

Thompson PM, Talbot RW, Packham DA, et al (1980) Transrectal biopsy of the prostate and bacteremia. Br J Surg 67:127–128PubMedCrossRef

46.

Thompson PM, Prior JP, Williams JP, et al (1982) The problem of infection after prostatic biopsy: the case for the transperineal approach. Br J Urol 54:736PubMed

47.

Shigemura K, Tanaka K, Yasuda M, Ishihara S, Muratani T, Deguchi T, Matsumoto T, Kamidono S, Nakano Y, Arakawa S, Fujisawa M (2005) Efficacy of 1-day prophylaxis medication with fluoroquinolone for prostate biopsy. World J Urol 23:356–360PubMedCrossRef

48.

Sieber PR, Rommel FM, Agusta VE, et al (1997) Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy. J Urol 157:2199–2200PubMedCrossRef

Titel: Biopsy standards for detection of prostate cancer
verfasst von: Bob Djavan
Markus Margreiter
Publikationsdatum: 01.03.2007
Verlag: Springer-Verlag
Erschienen in: World Journal of Urology / Ausgabe 1/2007
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-007-0151-1

Neu im Fachgebiet Urologie

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2007

Association of EMMPRIN and fascin expression in renal cell carcinoma: correlation with clinicopathological parameters

Molecular staging of prostate cancer in the year 2007

Endoscopic extraperitoneal radical prostatectomy: the University of Leipzig experience of 1,300 cases

Basic principles of anatomy for optimal surgical treatment of prostate cancer